[1] |
SONG Xu-jia, ZHANG Shi-jun, Lü Wen-xin, HUANG Lin, ZHANG Yan, WU Ming-gui, XIE Shao-wei.
Synergistic chemo-photothermal therapy of castration-resistant prostate cancersingle-walled carbon nanotube
[J]. , 2020, 40(4): 450-.
|
[2] |
HONG Xi1, LIU Li-jie1, HUANG Xian-yu2, LUO Jing2, YU Jian-jun1.
Effects of BRD4 inhibitor on histone crotonylation, proliferation and migration of prostate cancer cells
[J]. , 2019, 39(7): 721-.
|
[3] |
XIE Shao-wei,DONG Bai-jun,XIA Jian-guo,WANG Yan-qing,LI Hong-li,ZHANG Shi-jun,YANG Wen-qi,LI Feng-hua.
Value of prostate anterior horn biopsy in the diagnosis of prostate cancer
[J]. , 2019, 39(5): 518-.
|
[4] |
FANG Xiao1, 2, GUO Jian-gong1, HUANG Jin-ming1, FAN Lian-cheng2.
Prediction of prognostic nutritional index for the primary resistance to abiraterone and the prognosis in metastatic castration-resistant prostate cancer patients
[J]. , 2019, 39(3): 316-.
|
[5] |
LIU Li-jie1, HONG Xi1, HUANG Xian-yu3, LUO Jing3, YU Jian-jun1, 2.
Global levels of lysine crotonylation in prostate cancer and its correlation with clinical stages and pathologic grades
[J]. , 2018, 38(7): 788-.
|
[6] |
PAN Yu-long1, QI Jun2, ZHOU Liang1, ZHANG Tong-tong1, LI Qiang1.
Ribosomal protein 16 overexpresses in prostate cancer and promotes tumor progression
[J]. , 2018, 38(4): 394-.
|
[7] |
PAN Jia-hua, CHI Chen-fei, DONG Bai-jun, ZHU Yin-jie, SHAO Xiao-guang, WANG Yan-qing, XU Fan, SHA Jian-jun, HUANG Yi-ran, XUE Wei .
Safety of neoadjuvant chemo-hormonal therapy by the combination of docetaxel and maximal androgen blockage for locally advanced prostate cancer
[J]. , 2017, 37(6): 797-.
|
[8] |
FAN Lian-cheng*, DONG Bai-jun*, CHI Chen-fei, PAN Jia-hua, WANG Yan-qing, SHAO Xiao-guang, XU Fan, SHANGGUAN Xun, ZHOU Li-xin#, XUE Wei# .
Efficacy and prognostic factors of abiraterone combined with prednisone treating metastatic castration- resistant prostate cancer patients#br#
[J]. , 2017, 37(11): 1483-.
|
[9] |
FU Shi, ZHOU Juan, WANG Zhong .
Research progresses on the role of adiponectin and its receptors in prostate cancer#br#
[J]. , 2017, 37(10): 1434-.
|
[10] |
FAN Lian-cheng, DONG Bai-jun, CHI Chen-fei, PAN Jia-hua, SHA Jian-jun, HUANG Yi-ran, ZHOU Li-xin, XUE Wei.
Efficacy and safety of abiraterone combined with prednisone for treating chemotherapy-naive metastatic castration-resistant prostate cancer
[J]. , 2016, 36(09): 1306-.
|
[11] |
CHEN Xiao-xi, WU Lian-ming, ZHANG Xiao-fei, et al.
Correlation between IVIM diffusion-weighted MR imaging and Gleason score of prostate cancer
[J]. , 2014, 34(6): 868-.
|
[12] |
YANG Yan, CHEN Li.
Factors and interventions for mental disorders in patients with prostate cancer after androgen deprivation therapy
[J]. , 2011, 31(6): 730-.
|
[13] |
DING Yi-xing, QI Juan.
Research progress and clinical implication prospect of TMPRSS2-ETS fusion gene in prostate cancer
[J]. , 2011, 31(6): 852-.
|
[14] |
WU Qi-jun, XU Jian-feng, SHI Rong.
Research progress of susceptible genes and genetic epidemiology of prostate cancer
[J]. , 2011, 31(5): 672-.
|
[15] |
PAN Yi-fan, LIU Jian-jun, HUANG Gang, et al.
Application of bone scintigraphy in therapy response monitoring and prognosis prediction in patients with bone metastasis from lung cancer and prostate cancer
[J]. , 2011, 31(12): 1758-.
|